Increased immunogenicity of colon cancer cells by selective depletion of cytochrome c

被引:17
作者
Schmitt, E
Parcellier, A
Ghiringhelli, F
Casares, N
Gurbuxani, S
Droin, N
Hamai, A
Pequignot, M
Hammann, A
Moutet, M
Fromentin, A
Kroemer, G
Solary, E
Garrido, C
机构
[1] INSERM, U517, F-21000 Dijon, France
[2] CNRS, UMR 8125, F-8125 Villejuif, France
关键词
D O I
10.1158/0008-5472.CAN-03-2475
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We and others have previously reported in an in vivo rat colon cancer cell model that cell death precedes and is necessary for the development of a specific antitumoral immune response. To sensitize colon cancer cells to death, we depleted cytochrome c by stable transfection with an antisense construct. Cytochrome c depletion sensitizes human and rat colon cancer cells to a nonapoptotic, nonautophagic death induced by various stimuli. This increased sensitization to a necrosis-like cell death may be related to a decrease in cellular ATP levels and an increase in reactive oxygen species production caused by cytochrome e depletion. In vivo, depletion of cytochrome c decreases the tumorigenicity of colon cancer cells in syngeneic rats without influencing their growth in immune-deficient animals. Furthermore, decreased expression of cytochrome c in tumor cells facilitates in vivo "necrotic" cell death and the induction of a specific immune response. These results delineate a novel strategy to sensitize colon cancer cells to chemotherapy and to increase their immunogenicity in immunocompetent hosts.
引用
收藏
页码:2705 / 2711
页数:7
相关论文
共 36 条
[1]  
Bonnotte B, 1998, J IMMUNOL, V161, P1433
[2]   Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system [J].
Bonnotte, B ;
Larmonier, N ;
Favre, N ;
Fromentin, A ;
Moutet, M ;
Martin, M ;
Gurbuxani, S ;
Solary, E ;
Chauffert, B ;
Martin, F .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :5077-5083
[3]   Hsp27 negatively regulates cell death by interacting with cytochrome c [J].
Bruey, JM ;
Ducasse, C ;
Bonniaud, P ;
Ravagnan, L ;
Susin, SA ;
Diaz-Latoud, C ;
Gurbuxani, S ;
Arrigo, AP ;
Kroemer, G ;
Solary, E ;
Garrido, C .
NATURE CELL BIOLOGY, 2000, 2 (09) :645-652
[4]   Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo [J].
Bruey, JM ;
Paul, C ;
Fromentin, A ;
Hilpert, S ;
Arrigo, AP ;
Solary, E ;
Garrido, C .
ONCOGENE, 2000, 19 (42) :4855-4863
[5]   SPECIFICITY OF THE IMMUNE-RESPONSE LEADING TO PROTECTION OR ENHANCEMENT BY REGRESSIVE AND PROGRESSIVE VARIANTS OF A RAT COLON-CARCINOMA [J].
CAIGNARD, A ;
PELLETIER, H ;
MARTIN, F .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (06) :883-886
[6]  
CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155
[7]   Mitochondrion as a novel target of anticancer chemotherapy [J].
Costantini, P ;
Jacotot, E ;
Decaudin, D ;
Kroemer, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (13) :1042-1053
[8]  
Eguchi Y, 1997, CANCER RES, V57, P1835
[9]  
Favre-Felix N, 2000, INT J CANCER, V86, P827, DOI 10.1002/(SICI)1097-0215(20000615)86:6<827::AID-IJC11>3.0.CO
[10]  
2-R